List your tool

Head to head · 2026

Hippocratic AI vs MDClone

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Hippocratic AI

115 million patient interactions with zero safety incidents, and it still won't diagnose

4.3Not listed

Visit Hippocratic AI (opens Hippocratic AI in a new tab)

MDClone

Healthcare data platform that generates synthetic patient data for privacy-safe research and analytics

4.1Not listed

Visit MDClone (opens MDClone in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Hippocratic AI does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Hippocratic AI

    4.3 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onHippocratic AIMDClone
Our rating4.3Better4.1
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Patient-facing AI agents for pre-visit intake, follow-up, and check-ins
  • Deliberately restricted from prescribing or diagnosing by design
  • 115 million-plus clinical patient interactions with no reported safety issues
  • Partnerships with 50+ health systems, payers, and pharmaceutical companies
  • $126M Series C at a $3.5B valuation in November 2025
  • Synthetic patient data generation preserving real statistical patterns
  • Self-service query and exploration environment for non-technical analysts
  • Real-time access to large-scale healthcare datasets
  • Removes re-identification risk from research workflows
  • Deployable across health systems, payers, and life sciences organizations
Pros
  • Non-diagnostic scope reduces liability risk compared to diagnostic AI agents
  • Massive interaction volume with a clean safety record builds real trust
  • Strong recent funding at a high valuation supports continued expansion
  • Synthetic-data approach sidesteps lengthy IRB and de-identification review cycles
  • Nearly a decade of operating history in a conservative, compliance-heavy industry
  • Over $100 million raised signals sustained institutional backing
Cons
  • Enterprise pricing requires a sales conversation, no published self-serve rate
  • Deliberately limited scope means it won't replace diagnostic or prescribing tools
  • Young company, founded 2023, with a shorter track record than established competitors
  • No public pricing, with enterprise sales cycles typical of hospital software
  • Value concentrated in large health systems rather than small clinics
  • Synthetic data still requires validation against real cohorts for high-stakes research
CompanyHippocratic AI, founded 2023MDClone, founded 2016

Prices come from each vendor's pricing page, last checked 20260718. Check the vendor before you buy.

FAQ

Questions people ask

Is Hippocratic AI better than MDClone?

In our reviews Hippocratic AI scores 4.3 and MDClone scores 4.1. The better pick depends on the job. Hippocratic AI: 115 million patient interactions with zero safety incidents, and it still won't diagnose. MDClone: Healthcare data platform that generates synthetic patient data for privacy-safe research and analytics.

Which is cheaper, Hippocratic AI or MDClone?

Hippocratic AI: see pricing. MDClone: see pricing.

Do Hippocratic AI and MDClone have free plans?

Neither lists a free plan.

More comparisons